NewLimit, co-founded by Coinbase CEO Brian Armstrong, raised $45 million from Eli Lilly, Duke, and more to advance its anti-aging medicines.
NewLimit, a biotech company, is on a mission to reverse the features of aging by manipulating cell age without changing cell type.
Sign Up to Our Newsletter
